RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Colonya Calhoun to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Colonya Calhoun has written about Treatment Outcome.
Colonya Calhoun
Connection Strength
0.065
Treatment Outcome
  1. Calhoun CC, Cardenes O, Ducksworth J, Le AD. Off-label use of becaplermin gel (recombinant platelet-derived growth factor-BB) for treatment of mucosal defects after corticocancellous bone graft: report of 2 cases with review of the literature. J Oral Maxillofac Surg. 2009 Nov; 67(11):2516-20.
    View in: PubMed
    Score: 0.065
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support